Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
Accretion Pharmaceuticals Ltd. is in a competitive pharmaceutical landscape with peers showing varied strengths in growth, profitability, and valuation. Companies like Dr. Reddy's Laboratories and Cipla stand out for their profitability, while firms like Divi's Laboratories show concerning growth metrics. Overall, the analysis reveals a mix of strong performers and financially risky companies, indicating a need for careful selection in the sector.
Highest ROE and ROCE, strong EPS growth, and low PE ratio.
High profitability with solid ROA and ROE, attractive valuation metrics.